Medical/Pharmaceuticals
IBC Launches Full Range of Best-in-Class Molecular Recognition Technology™ (MRT™) Flowsheets for Highly Selective Separations of Key Radionuclides and Preparation of Novel Chelating Agents for Radionuclide Incorporation into Radiopharmaceuticals
* Development of multiple anticancer drugs with radioisotopes is in progress * Lu-177, Y-90, Cu-67, Ra-223, Ac-225, Pb-212 and At-211 have licensed products or are in clinical trials * IBC's state-of-the-art MRT™ separation and chelation technologies facilitate production of radiopharmaceuti...
2023-06-20 22:21
2885
Subang Jaya Medical Centre Awarded Frost & Sullivan's Company of the Year Award for the Third Consecutive Year
SJMC's long history of clinical and service excellence and expertise in certain areas, such as oncology and orthopedics, points to its robust performance. SAN ANTONIO, June 20, 2023 /PRNewswire/ -- Frost & Sullivan assessed the Malaysian healthcare industry and, based on its findings, recognizesS...
2023-06-20 09:00
1187
Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster
PHILADELPHIA, June 20, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease, has tapped Irena Lerentracht Webster to join its board of directors.Webster is...
2023-06-20 07:00
1045
AWAK Technologies and Singapore General Hospital launch pre-pivotal clinical trial of wearable peritoneal dialysis device
SINGAPORE, June 20, 2023 /PRNewswire/ -- AWAK Technologies (AWAK) and Singapore General Hospital (SGH) announce the launch of a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dial...
2023-06-20 06:00
1671
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 19, 2023 /PRNewswire/ -- Sirnaomics Ltd.(the "Company"; stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced the adv...
2023-06-19 21:29
3666
Allgenesis Announces Encouraging Phase 1b Data Showing AG-80308 Providing Improvements in Multiple Signs and Symptoms in Dry Eye Patients
ALHAMBRA, Calif., June 19, 2023 /PRNewswire/ -- Allgenesis Biotherapeutics Inc., a clinical-stage specialty pharmaceutical company focused on developing novel ophthalmic drugs, today announced topline data from the company's Phase1b clinical trial for AG-80308, a first-in-class, formyl peptide re...
2023-06-19 16:00
1454
Novel Transcatheter Valve Repair Device: DRAGONFLY-DMR 12-Month Trial Results Revealed at EuroPCR 2023
First-Time Clinical Trial Outcomes Show Promising Follow-Up Results HANGZHOU, China, June 19, 2023 /PRNewswire/ -- On May 17th, the 12-month results of the DRAGONFLY-DMR pivotal trial were presented at EuroPCR 2023. This trial was led by Professor Jian'an Wang from Zhe'er Hospital,Hangzhou, China...
2023-06-19 14:35
1488
TCM contributes "Chinese scripts" to Cambodia's epidemic prevention, global health governance
BEIJING, June 19, 2023 /PRNewswire/ -- A news report by haiwainet.cn: In recent years, Chinese hospitals, represented by Xiyuan Hospital under the China Academy of Chinese Medical Sciences, have made remarkable progress in overseas traditional Chinese medicine(TCM) clinics, training and exchange...
2023-06-19 13:51
1442
First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion
MELBOURNE, Australia, June 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II study of the Company's carbonic anhydrase- (CAIX)-targeting PET/CT[1] imaging agent TLX250-CDx (89Zr-DFO-girentuxima...
2023-06-19 08:16
1727
Mallinckrodt Announces Publication of Real-World Data on the Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients
- Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of ECP in heart transplant patients reinforce its use as a treatment for heart transplant rejection and prevention of rejection1 - DUBLIN, June 19, 2023 /PR...
2023-06-19 06:30
2334
The 'Penicillin' of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug
- Professor Heungjeong Woo of Hallym University College of Medicine, announced the result of Xafty's clinical study at Emerging Science Session of the American Society for Microbiology (ASM) Microbe 2023 - Dr. Jo White evaluated Xafty's clinical results as "The birth of Penicillin of Antivirals"...
2023-06-18 03:30
3678
Molfix Bond with Love Secure Attachment Bond Program was Honored with The International CSR Excellence Awards in its 5th Year
Bond with Love Secure Attachment Bond Program of Molfix, which supports the happy and healthy development of babies and is a reliable companion of mothers with its innovative approach, was honored with "The International CSR Excellence Awards" LONDON, June 17, 2023 /PRNewswire/ -- Molfix Bond wi...
2023-06-17 13:00
2997
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE
SUZHOU, China, June. 17, 2023 /PRNewswire/ -- The 4th Academic Annual Conference held by the Mechanical Circulatory Support (MCS) Branch of the Chinese Society of Biomedical Engineering (CSBE), one of the biggest academic gatherings that celebrate the latest accomplishments in technological inn...
2023-06-17 07:08
3781
Apollo Hospitals Eliminates 2,90,000 Tons of Carbon with Smart Joules, Strengthening India's Decarbonization Efforts
NEW DELHI, June 16, 2023 /PRNewswire/ -- Apollo Hospitals, the world's largest vertically integrated healthcare provider, has joined hands with Smart Joules to reduce carbon emissions by an astounding 2,90,000 tons, bolsteringIndia's efforts to decarbonize. This ten-year initiative spans 18 hospi...
2023-06-16 15:33
2822
Wellness expert Ananchi introduces new Japanese technology, offers advanced bust beauty care and fertility treatments with new center in Central Hong Kong
HONG KONG, June 16, 2023 /PRNewswire/ -- Wellness and beauty expert Ananchi today announces the opening of a new center inCentral Hong Kong, and unveils a multi-million dollar expansion plan which includes investment in the latest health and wellness technology. Since its inception in 2019, Ananc...
2023-06-16 15:00
2121
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
HONG KONG, June 16, 2023 /PRNewswire/ -- On June 11, 2023, Viva Biotech Holdings Group (1873.HK) announced that Viva Shanghai, the primary entity for Viva Biotech's CRO business, successfully raised nearlyUS$ 150 million through the transfer of approximately 24% of its equity interest to Temasek,...
2023-06-16 14:20
5539
NABR Files Petition Challenging the Listing of Long-Tailed Macaque by the IUCN
WASHINGTON, June 16, 2023 /PRNewswire/ -- Working with recognized, independent scientists, the National Association for Biomedical Research (NABR) filed a petition today with the International Union for Conservation of Nature (IUCN) challenging the recent designation of the long-tailed macaque (C...
2023-06-16 10:30
4759
Everest Medicines Appoints Dr. Mike Berry as Chief Technology Officer
SHANGHAI, June 16, 2023 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on development, manufacturing and commercialization of innovative medicines and vaccines, today announced that Dr.Mike Berry has been appointed Chief Techno...
2023-06-16 07:45
2508
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall
* Novavax has developed a protein-based monovalent XBB.1.5 COVID vaccine candidate and is manufacturing at commercial scale with the intent to be in market during the fall vaccination campaign * Novavax shared data demonstrating that its XBB.1.5 COVID vaccine candidate induces functional immu...
2023-06-16 06:05
2553
Qiming Venture Partners fosters life science, medical and healthcare talent development First healthcare catalyst program starts recruiting in Hong Kong universities
SHANGHAI and HONG KONG, June 15, 2023 /PRNewswire/ -- Qiming Venture Partners ("Qiming") today launched its first "Catalyst: Qiming Healthcare Summer Program 2023" for universities inHong Kong, fostering talent development and cross-border integration for the life science, medical and healthcare ...
2023-06-15 22:58
3055
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
